Katalyze AI provides an agentic operating system for pharmaceutical companies that unifies fragmented production data into a single source-grounded record and runs a catalog of domain-trained agents. The company is led by CEO Reza Farahani and is based in Mountain View, CA. Its platform is already deployed across five of the 20 largest global pharma companies. Katalyze reports that its solution has enabled pharma teams to deliver 10 million medication doses to patients. The company intends to use the Seed proceeds to expand operations and accelerate product development. The article does not disclose revenue, valuation, or prior funding details.

Total raised

$11M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2026